Nasonex
Nasonex is a medicine authorised by Swissmedic under authorisation number 70546. The authorisation holder is EurimPharm Swiss AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 02 April 2026 and the authorisation is limited until 01 April 2031. ATC code R01AD09 places the medicine in the group Nasal preparations.
| Authorisation number | 70546 |
|---|---|
| Name | Nasonex |
| Full name | Nasonex, Dosier-Nasenspray |
| Authorisation holder | EurimPharm Swiss AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R01AD09 |
| First authorisation | 02 April 2026 |
| Authorisation validity | 01 April 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Nasonex, Dosier-Nasenspray | B | 02 April 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 140 | Einzeldose(n) | R01AD09 | 12.02.3. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Nasonex authorised in Switzerland?
Yes. Nasonex is authorised by Swissmedic under authorisation number 70546, data as of 01 September 2026. The authorisation is limited until 01 April 2031.
Which dispensing category does Nasonex have?
Nasonex is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Nasonex?
The authorisation holder is EurimPharm Swiss AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.